BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19172901)

  • 21. Caspase-dependent N-terminal cleavage of influenza virus nucleocapsid protein in infected cells.
    Zhirnov OP; Konakova TE; Garten W; Klenk H
    J Virol; 1999 Dec; 73(12):10158-63. PubMed ID: 10559331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Impact of mutations in nucleoprotein on replication of influenza virus A/Hong Kong/1/68/162/35 reassortants at different temperatures].
    Pulkina AA; Sergeeva MV; Petrov SV; Fadeev AV; Komissarov AB; Romanovskaya-Romanko EA; Potapchuk MV; Tsybalova LM
    Mol Biol (Mosk); 2017; 51(2):378-383. PubMed ID: 28537245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An A14U Substitution in the 3' Noncoding Region of the M Segment of Viral RNA Supports Replication of Influenza Virus with an NS1 Deletion by Modulating Alternative Splicing of M Segment mRNAs.
    Zheng M; Wang P; Song W; Lau SY; Liu S; Huang X; Mok BW; Liu YC; Chen Y; Yuen KY; Chen H
    J Virol; 2015 Oct; 89(20):10273-85. PubMed ID: 26223635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenic potential of North American H7N2 avian influenza virus: a mutagenesis study using reverse genetics.
    Lee CW; Lee YJ; Senne DA; Suarez DL
    Virology; 2006 Sep; 353(2):388-95. PubMed ID: 16828833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic analysis of the compatibility between polymerase proteins from human and avian strains of influenza A viruses.
    Naffakh N; Massin P; Escriou N; Crescenzo-Chaigne B; van der Werf S
    J Gen Virol; 2000 May; 81(Pt 5):1283-91. PubMed ID: 10769071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel mutations in avian PA in combination with an adaptive mutation in PR8 NP exacerbate the virulence of PR8-derived recombinant influenza A viruses in mice.
    Lee CY; An SH; Kim I; Choi JG; Lee YJ; Kim JH; Kwon HJ
    Vet Microbiol; 2018 Jul; 221():114-121. PubMed ID: 29981696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics.
    Lu B; Zhou H; Ye D; Kemble G; Jin H
    J Virol; 2005 Jun; 79(11):6763-71. PubMed ID: 15890915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basic residues of the helix six domain of influenza virus M1 involved in nuclear translocation of M1 can be replaced by PTAP and YPDL late assembly domain motifs.
    Hui EK; Barman S; Yang TY; Nayak DP
    J Virol; 2003 Jun; 77(12):7078-92. PubMed ID: 12768027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incorporation of conserved nucleoprotein into influenza virus-like particles could provoke a broad protective immune response in BALB/c mice and chickens.
    Xue C; Tian G; Chen X; Liu Q; Ma J; Xu S; Li X; Chen H; Cao Y
    Virus Res; 2015 Jan; 195():35-42. PubMed ID: 25312452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electroporation of influenza virus ribonucleoprotein complexes for rescue of the nucleoprotein and matrix genes.
    Li S; Xu M; Coelingh K
    Virus Res; 1995 Jul; 37(2):153-61. PubMed ID: 7483828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fundamental Contribution and Host Range Determination of ANP32A and ANP32B in Influenza A Virus Polymerase Activity.
    Zhang H; Zhang Z; Wang Y; Wang M; Wang X; Zhang X; Ji S; Du C; Chen H; Wang X
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Characterization of proteolytic cleavage of influenza virus nucleocapsid protein NP in infected cells].
    Zhirnov OP; Konakova TE; Garten W; Klenk HD
    Vopr Virusol; 1999; 44(6):275-9. PubMed ID: 10665065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-wide RNAi screen for viral replication in mammalian cell culture.
    Prusty BK; Karlas A; Meyer TF; Rudel T
    Methods Mol Biol; 2011; 721():383-95. PubMed ID: 21431699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
    Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
    Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A serine-to-asparagine mutation at position 314 of H5N1 avian influenza virus NP is a temperature-sensitive mutation that interferes with nuclear localization of NP.
    Siboonnan N; Wiriyarat W; Boonarkart C; Chakritbudsabong W; Jongkaewwattana A; Puthavathana P; Auewarakul P; Suptawiwat O
    Arch Virol; 2013 Jun; 158(6):1151-7. PubMed ID: 23307364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of seal influenza virus variants pathogenic for chickens, because of hemagglutinin cleavage site changes.
    Li SQ; Orlich M; Rott R
    J Virol; 1990 Jul; 64(7):3297-303. PubMed ID: 2191148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional compensation of a detrimental amino acid substitution in a cytotoxic-T-lymphocyte epitope of influenza a viruses by comutations.
    Rimmelzwaan GF; Berkhoff EG; Nieuwkoop NJ; Fouchier RA; Osterhaus AD
    J Virol; 2004 Aug; 78(16):8946-9. PubMed ID: 15280506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Construction and immunogenicity of recombinant bacteriophage T7 vaccine expressing M2e peptides of avian influenza virus].
    Xu H; Wang YW; Tang YH; Zheng QS; Hou JB
    Bing Du Xue Bao; 2013 Jun; 29(4):376-81. PubMed ID: 23895000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth of influenza A virus is not impeded by simultaneous removal of the cholesterol-binding and acylation sites in the M2 protein.
    Thaa B; Tielesch C; Möller L; Schmitt AO; Wolff T; Bannert N; Herrmann A; Veit M
    J Gen Virol; 2012 Feb; 93(Pt 2):282-292. PubMed ID: 22012459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.